149 related articles for article (PubMed ID: 10688987)
1. Electrical and mechanical effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in the rat colon involve different mechanisms.
Plujà L; Fernández E; Jiménez M
Eur J Pharmacol; 2000 Feb; 389(2-3):217-24. PubMed ID: 10688987
[TBL] [Abstract][Full Text] [Related]
2. VIP- and PACAP-mediated nonadrenergic, noncholinergic inhibition in longitudinal muscle of rat distal colon: involvement of activation of charybdotoxin- and apamin-sensitive K+ channels.
Kishi M; Takeuchi T; Suthamnatpong N; Ishii T; Nishio H; Hata F; Takewaki T
Br J Pharmacol; 1996 Oct; 119(4):623-30. PubMed ID: 8904634
[TBL] [Abstract][Full Text] [Related]
3. The possible role of ATP and PACAP as mediators of apaminsensitive NANC inhibitory junction potentials in circular muscle of guinea-pig colon.
Zagorodnyuk V; Santicioli P; Maggi CA; Giachetti A
Br J Pharmacol; 1996 Nov; 119(5):779-86. PubMed ID: 8922721
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evidence for both neuronal and smooth muscular PAC1 receptors and a VIP-specific receptor in rat colon.
Ekblad E
Regul Pept; 1999 Dec; 85(2-3):87-92. PubMed ID: 10651061
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of neuronal and smooth muscle receptors involved in the VIP- and PACAP-induced relaxations of the pig intravesical ureter.
Hernández M; Barahona MV; Recio P; Rivera L; Benedito S; Martínez AC; García-Sacristán A; Orensanz LM; Prieto D
Br J Pharmacol; 2004 Jan; 141(1):123-31. PubMed ID: 14662737
[TBL] [Abstract][Full Text] [Related]
6. Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle.
Ekblad E; Sundler F
Eur J Pharmacol; 1997 Sep; 334(1):61-6. PubMed ID: 9346329
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the NANC relaxation of the guinea-pig proximal colon longitudinal muscle by the purinoceptor antagonist PPADS, inhibition of nitric oxide synthase, but not by a PACAP/VIP antagonist.
Rózsai B; Lázár Z; Benkó R; Barthó L
Pharmacol Res; 2001 Jan; 43(1):83-7. PubMed ID: 11207070
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase involvement in apamin-sensitive inhibitory responses of rat distal colon.
Takeuchi T; Kishi M; Hirayama N; Yamaji M; Ishii T; Nishio H; Hata F; Takewaki T
J Physiol; 1999 Jan; 514 ( Pt 1)(Pt 1):177-88. PubMed ID: 9831725
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory pathways in the circular muscle of rat jejunum.
Vanneste G; Robberecht P; Lefebvre RA
Br J Pharmacol; 2004 Sep; 143(1):107-18. PubMed ID: 15302684
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of PACAP(6-38) on relaxations induced by PACAP, VIP and non-adrenergic, non-cholinergic nerve stimulation in the guinea-pig taenia caeci.
Lénárd L; Lázár Z; Benkó R; Szigeti R; Báthori Z; Tóth GK; Penke B; Barthó L
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):492-7. PubMed ID: 10832602
[TBL] [Abstract][Full Text] [Related]
11. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory transmission in tenia coli mediated by distinct vasoactive intestinal peptide and apamin-sensitive pituitary adenylate cyclase activating peptide receptors.
Jin JG; Katsoulis S; Schmidt WE; Grider JR
J Pharmacol Exp Ther; 1994 Aug; 270(2):433-9. PubMed ID: 8071835
[TBL] [Abstract][Full Text] [Related]
13. Characterization of intestinal receptors for VIP and PACAP in rat and in PAC1 receptor knockout mouse.
Ekblad E; Jongsma H; Brabet P; Bockaert J; Sundler F
Ann N Y Acad Sci; 2000; 921():137-47. PubMed ID: 11193817
[TBL] [Abstract][Full Text] [Related]
14. PACAP-(6-38) inhibits the effects of vasoactive intestinal polypeptide, but not PACAP, on the small intestinal circular muscle.
Lázár Z; Shahbazian A; Benkó R; Tóth G; Penke B; Barthó L; Holzer P
Eur J Pharmacol; 2001 Nov; 431(2):259-64. PubMed ID: 11728434
[TBL] [Abstract][Full Text] [Related]
15. Interactive mechanisms among pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide, and parathyroid hormone receptors in guinea pig cecal circular smooth muscle cells.
Motomura Y; Chijiiwa Y; Iwakiri Y; Ochiai T; Nawata H
Endocrinology; 1998 Jun; 139(6):2869-78. PubMed ID: 9607796
[TBL] [Abstract][Full Text] [Related]
16. Pituitary adenylate cyclase-activating peptide is a potent modulator of human colonic motility.
Schwörer H; Clemens A; Katsoulis S; Köhler H; Creutzfeldt W; Schmidt WE
Scand J Gastroenterol; 1993 Jul; 28(7):625-32. PubMed ID: 8362218
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase-activating polypeptide stimulates cardiodilatin/atrial natriuretic peptide (CDD/ANP-(99-126) secretion from cultured neonatal rat myocardiocytes.
Bäsler I; Kuhn M; Müller W; Forssmann WG
Eur J Pharmacol; 1995 Nov; 291(3):335-42. PubMed ID: 8719418
[TBL] [Abstract][Full Text] [Related]
18. Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide.
Absood A; Chen D; Wang ZY; Håkanson R
Regul Pept; 1992 Aug; 40(3):323-9. PubMed ID: 1332142
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase activating peptide mediates inhibitory nonadrenergic noncholinergic relaxation.
Yoshida M; Aizawa H; Takahashi N; Shigyo M; Hara N
Eur J Pharmacol; 2000 Apr; 395(1):77-83. PubMed ID: 10781677
[TBL] [Abstract][Full Text] [Related]
20. The P(2)-purinoceptor antagonist suramin is a competitive antagonist at vasoactive intestinal peptide receptors in the rat gastric fundus.
Jenkinson KM; Reid JJ
Br J Pharmacol; 2000 Aug; 130(7):1632-8. PubMed ID: 10928968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
